Month: August 2020

Net sales were €19.1 billion, up 17.1%, or 15.9% at constant exchange ratesIn the U.S. and Europe, comp sales growth excluding gas was up 20.6% and 10.2%, respectivelyNet consumer online sales grew 77.6% at constant exchange rates; Ahold Delhaize will reach €7 billion net consumer online sales goal in 2020, one year ahead of planCOVID-19-related costs were approximately €330 million in the first half of the year, and approximately €260 million in Q2, including safety measures and enhanced associate pay  Operating income was €1,004 million, increasing 78.0% at constant exchange ratesUnderlying operating margin was 5.3%, up 1.7% points from the prior year at constant exchange ratesDiluted EPS was €0.65; diluted underlying EPS was €0.65, increasing 87.9%2020 outlook raised, with underlying EPS growth in the low-to-mid-20% range; free cash...

                                                                Nasdaq CopenhagenLondon Stock ExchangeOther stakeholders5 August 2020Ringkjøbing Landbobank’s interim report for the first half of 2020The financial results for the half-year are affected by the corona crisis. We are pleased, in this context, that the bank’s business model is robust, with a low rate of costs and a strong capital base.Core earningsHighlights of the first half of 2020Our main focus during the corona crisis has been to help our customers and business partners – and of course to safeguard the working conditions of our employeesIncome increases by 1% and expenses fall by 4%, reducing the bank’s rate of costs to 36.8%The management estimate for impairment charges in the second quarter of 2020 has increased by DKK 198 million after impairment charges of DKK 66 million...

                                                                Nasdaq CopenhagenLondon Stock ExchangeØvrige interessenter5. august 2020Ringkjøbing Landbobanks halvårsrapport for 1. halvår 2020Halvårets regnskabsresultater er påvirket af Corona-krisen. I den forbindelse er det glædeligt, at bankens forretningsmodel er robust med en lav omkostningsprocent og en stærk kapitalbase.Basisresultat1. halvår 2020 i overskrifterVores hovedfokus under Corona-krisen har været på at hjælpe vores kunder og samarbejdspartnere– og selvfølgelig på at sikre arbejdsforholdene for vores medarbejdereIndtægterne stiger med 1%, og udgifterne falder med 4%, dermed falder bankens omkostningsprocent til 36,8Det ledelsesmæssige skøn på nedskrivninger forhøjes i 2. kvartal 2020 med 198 mio. kroner efter driftsmæssige nedskrivninger i kvartalet på 66 mio....

AttachmentEN_Kepler liquidity contract 2020 PR_20200805_F

 Pièce jointeFR_Kepler liquidity contract 2020 PR_20200805_F

  Investors House Oyj                                                                          Lehdistötiedote 5.8.2020 klo 8.00INVESTORS HOUSE: OPISKELIJAVALINNAT HEILUTTAVAT VUOKRA-ASUNTO MARKKINAATämä kesä on ollut erilainen kuin aikaisemmat. Opiskelijavalintojen muutokset ovat heiluttaneet vuokra-asunto markkinaa.”Koronan takia opiskelijavalinnat eri asteisissa oppilaitoksissa on tehty eri tavalla kuin aiemmin. Tämän johdosta on vuokra-asunto markkina ”sotkeentunut”. Siinä missä yleensä heinäkuulla opiskelijat ovat rynnänneet vuokraamaan vuokra-asuntoja, on kysyntä jakaantunut koko kesälle tasaisemmin. Tämä on yllättänyt osan vuokranantajista. Kesäkuu oli OVV ketjussa ennätyksellinen ja heinäkuu hieman vaisumpi aiempaan vuoteen verrattuna. Mielestäni kysynnän jakaantuminen tasaisemmin on hyvä vuokra-asunnon hakijoille ja vuokranantajille.”...

Schlieren/Switzerland, 5 August 2020ARYZTA AG announces that Frederic Pflanz has notified the Board that he will step down as Group Chief Financial Officer (CFO) in December. Frederic has accepted a role in an unrelated business.The news release can be downloaded from the following link:AttachmentRelease

Amsterdam, 5 August 2020 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announces that it has signed a share purchase and sale agreement with its local partner Porto de Cima Concessões S.A. and has transferred the shares it holds in Arcadis Logos Energia S.A. (‘ALEN’) as per today.In December 2019 Arcadis decided to stop investing in the ALEN associate and its participations in the clean energy assets in Brazil and took a provision to cover the full exposure. As a result of today’s transaction €6 million of guaranteed debt by Arcadis will be repaid and part of the provisions will be released.Peter Oosterveer, CEO of Arcadis says: “I am very pleased that we reached an agreement to transfer our shares in the ALEN associate to our local partner. After we stopped...

Schiphol, the Netherlands – 5 August 2020. GrandVision N.V. publishes the Half Year and Second Quarter 2020 results.Half year and second quarter 2020 highlightsRevenue declined by 26.4% at constant exchange rates in HY20 (HY19: +7.3%) and 47.5% in 2Q20 (2Q19: +7.1%) as a result of store closures related to the coronavirus pandemic. Comparable revenue declined by 29.1% in HY20 and 49.3% in 2Q20HY20 adj. EBITA was -€24 million in HY20 (HY19: €237 million) and -€65 million in 2Q20, driven by negative operating leverage, particularly in April and MayDuring the month of June, more than 90% of GrandVision’s store network gradually reopened, leading to strong recovery of revenue and a positive adjusted EBITAGrandVision booked a non-cash goodwill impairment charge of €75 million, related to our businesses in the US, Italy, Colombia and...

FDA granted de novo class II for cobas EBV test following the agency’s Breakthrough Device designationAccurate monitoring of Epstein-Barr virus DNA levels is critical, as they are  associated with a range of life threatening-diseases including cancer in transplant patientsTest meets World Health Organization standards for consistent result reporting among laboratories across the U.S., allowing for results to be easily comparable across hospitals and labsBasel, 5 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has authorised the cobas® EBV test. This is the first quantitative in vitro diagnostic test for Epstein-Barr virus (EBV) DNA in the United States. This authorisation gives healthcare professionals a key tool in monitoring transplant patients at risk for complications...